Original Research

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation

Yi ZM, Qiu TT, Zhang Y, Liu N, Zhai SD

Therapeutics and Clinical Risk Management 2018, 14:709-719

Published Date: 16 April 2018